A webinar on myasthenia gravis featuring Hana Axelrod, MD, MPH and Henry J. Kaminski, MD, of MGNet talk about COVID-19 and its impacts on myasthenia gravis patients.

The National Institutes of Health (NIH) awarded a research team at the George Washington University (GW) $7.8 million to establish a rare disease network for myasthenia gravis. The network, which will become one of 23 established NIH Rare Diseases Clinical Research Networks, will include basic and clinical investigators, patient advocacy groups, and biotechnology and pharmaceutical companies working together to enhance therapeutic development for this rare disease.